Chesley Taft & Associates LLC reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 9.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,976 shares of the pharmacy operator’s stock after selling 1,650 shares during the quarter. Chesley Taft & Associates LLC’s holdings in Walgreens Boots Alliance were worth $143,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in WBA. Czech National Bank increased its stake in Walgreens Boots Alliance by 7.0% in the third quarter. Czech National Bank now owns 145,962 shares of the pharmacy operator’s stock worth $1,308,000 after purchasing an additional 9,512 shares during the period. Central Pacific Bank Trust Division grew its holdings in shares of Walgreens Boots Alliance by 77.8% in the third quarter. Central Pacific Bank Trust Division now owns 8,000 shares of the pharmacy operator’s stock worth $72,000 after purchasing an additional 3,500 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its stake in Walgreens Boots Alliance by 96.8% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 5,527 shares of the pharmacy operator’s stock worth $50,000 after buying an additional 2,719 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Walgreens Boots Alliance during the 2nd quarter valued at about $958,000. Finally, Clifford Capital Partners LLC boosted its position in Walgreens Boots Alliance by 58.4% in the 2nd quarter. Clifford Capital Partners LLC now owns 803,204 shares of the pharmacy operator’s stock valued at $9,715,000 after buying an additional 296,135 shares during the period. Institutional investors own 58.59% of the company’s stock.
Walgreens Boots Alliance Stock Up 2.4 %
Shares of Walgreens Boots Alliance stock opened at $9.08 on Wednesday. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. The company has a market cap of $7.84 billion, a P/E ratio of -1.35, a PEG ratio of 0.99 and a beta of 0.70. The firm’s 50 day moving average price is $9.67 and its 200-day moving average price is $13.73. Walgreens Boots Alliance, Inc. has a 52-week low of $8.22 and a 52-week high of $27.05.
Analyst Upgrades and Downgrades
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
- Five stocks we like better than Walgreens Boots Alliance
- What Do S&P 500 Stocks Tell Investors About the Market?
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.